GLASS J KENNETH

CIK 00012249663 companiesMEMPHIS, TN

SEC Profile

Transactions

Companies

Filings

CIK

0001224966

Recent Transactions

50 trades

Award
Oncternal Therapeutics, Inc.
Director Stock Option (Right to Buy)
2018-05-10+7,500→ 7,500 total
Award
Oncternal Therapeutics, Inc.
Director Stock Option (Right to Buy)
2017-05-12+15,000→ 15,000 total
Award
Oncternal Therapeutics, Inc.
Director Stock Option (Right to Buy)
2016-05-05$0.71/sh+50,000→ 50,000 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2016-03-01$0.60/sh+44,000→ 183,767.58 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2015-12-24$0.79/sh+100→ 139,767.58 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2015-12-23$0.79/sh+600→ 139,667.58 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2015-12-22$0.78/sh+1,307→ 139,067.58 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2015-12-21$0.78/sh+39,900→ 137,760.58 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2015-05-19$1.25/sh+24,500→ 24,500 total
Award
Oncternal Therapeutics, Inc.
Director Stock Option (Right to Buy)
2015-05-07$0.76/sh+100,000→ 100,000 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2015-04-22$0.72/sh+10,000→ 97,860.58 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2015-04-21$0.71/sh+7,656→ 87,860.58 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2015-04-20$0.72/sh+3,952→ 80,204.58 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2015-04-15$0.72/sh+3,300→ 76,252.58 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2015-04-10$0.67/sh+16,400→ 72,952.58 total
Award
Oncternal Therapeutics, Inc.
Director Stock Option (Right to Buy)
2013-05-03$4.85/sh+20,000→ 20,000 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2012-08-27$3.76/sh+10,000→ 40,550 total
Award
Oncternal Therapeutics, Inc.
Director Stock Option (Right to Buy)
2012-05-04$3.02/sh+15,000→ 15,000 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2011-06-06$6.27/sh+16,050→ 87,102.58 total
Award
Oncternal Therapeutics, Inc.
Director Stock Option (Right to Buy)
2011-05-06$5.40/sh+15,000→ 15,000 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2011-04-15$3.83/sh+15,000→ 71,052.58 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2010-06-22$2.70/sh+7,500→ 56,052.58 total
Award
Oncternal Therapeutics, Inc.
Director Stock Option (Right to Buy)
2010-04-30$3.28/sh+10,000→ 10,000 total
Award
Oncternal Therapeutics, Inc.
Director Stock Option (Right to Buy)
2009-05-07$9.53/sh+10,000→ 10,000 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2009-02-12$10.27/sh+5,000→ 48,552.58 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2009-01-28$10.65/sh+5,000→ 43,552.58 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2007-12-31$14.35/sh+209.06→ 38,552.59 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2007-10-01$16.28/sh+307.13→ 38,343.53 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2007-09-30$16.28/sh+138.21→ 38,036.4 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2007-07-01$16.19/sh+308.83→ 37,898.19 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2007-05-07$19.92/sh+800→ 19,989.36 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2007-05-07$19.91/sh+1,979→ 21,968.36 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2007-05-07$19.96/sh+119→ 17,708.36 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2007-05-07$19.93/sh+100→ 19,189.36 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2007-05-07$19.89/sh+1,779→ 27,268.36 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2007-05-07$19.87/sh+200→ 27,589.36 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2007-05-07$19.95/sh+1,081→ 18,789.36 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2007-05-07$19.90/sh+3,521→ 25,489.36 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2007-05-07$19.94/sh+300→ 19,089.36 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2007-05-07$19.88/sh+121→ 27,389.36 total
Sale
FIRST HORIZON CORP$FHN
Common Stock
2007-02-20$44.77/sh−48,458→ 406,161 total
Exercise/Conversion
FIRST HORIZON CORP$FHN
Stock Options (Right to buy)
2007-02-16$21.13/sh−48,458→ 0 total
Exercise/Conversion
FIRST HORIZON CORP$FHN
Common Stock
2007-02-16$21.13/sh+48,458→ 454,619 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2007-01-01$17.84/sh+280.27→ 17,344.26 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2006-10-01$9.24/sh+541.13→ 17,063.99 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2006-07-01$9.10/sh+549.45→ 16,522.86 total
Award
Oncternal Therapeutics, Inc.
Director Stock Option (Right to Buy)
2006-04-27$10.08/sh+8,000→ 8,000 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2006-04-01$10.92/sh+457.88→ 5,973.41 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2006-01-01$7.56/sh+661.38→ 5,515.53 total
Award
Oncternal Therapeutics, Inc.
Common Stock
2005-09-30$9.31/sh+537.06→ 4,854.15 total

GLASS J KENNETH

Recent Transactions

Companies

Recent Filings

Address